The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Trimethoprim-Sulfamethoxazole: In Vitro Microbiological Aspects
Abstract
The ultimate effect on bacteria of trimethoprim (TMP) and sulfamethoxazole (SMZ) is to deprive them of folate coenzymes; the spectra of in vitro activity of TMP and SMZ are therefore similar although TMP is usually 20–100 times more active than is SMZ. The synergy of TMP and SMZ can be demonstrated in vitro by increases in bacteriostatic and bactericidal activities. There is an optimal ratio for producing these effects, and it corresponds to the ratios of the MIC of each drug when acting alone; however, synergy does occur over a wide range of ratios. The in vitro activity of TMP-SMZ depends on the medium in which it is measured; traces of thymidine will almost completely abolish activity. The size of the inoculum also affects activity. The activity is not affected in vitro or in vivo by the presence of exogenous folates except in the case of Streptococcus faecalis. Resistance to one of the drugs as measured by conventional tests may not abolish synergy; synergy is maximal, however, when the organism is susceptible to both drugs. Multiple studies have confirmed that TMP-SMZ has a wide spectrum of in vitro activity. The only outstanding exception is Pseudomonas aeruginosa. From heavy inocula, resistance to TMP develops rapidly, but the rate is markedly reduced by the presence of SMZ. The retarding effects of the sulfonamide depend on the degree of susceptibility of the organism and become small with highly resistant strains. R-factors conferring resistance to TMP have been identified, although at present they are rare. Susceptibility testing presents no problems provided a suitable medium and a small inoculum are used. A single combined disk containing 1.25 µg of TMP and 23.75 µg of SMZ is adequate for routine tests.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antibiotic Susceptibility Testing by a Standardized Single Disk Method
Bauer, A. W., Kirby, W. M. M., Sherris, J. C., & Turck, M. (1966) · American Journal of Clinical Pathology · doi:10.1093/ajcp/45.4_ts.493 · Cited by 18,523
Cited by
Rock, J. M., Hopkins, F. F., Chavez, A., Diallo, M., Chase, M. R., Gerrick, E. R., Pritchard, J. R., Church, G. M., Rubin, E. J., Sassetti, C. M., et al. (2017) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.274 · Cited by 538
Trimethoprim-Sulfamethoxazole Revisited
Masters, P. A., O'Bryan, T. A., Zurlo, J., Miller, D. Q., & Joshi, N. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.4.402 · Cited by 408
Markowitz, N., Quinn, E. L., & Saravolatz, L. D. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-5-390 · Cited by 343
Zervos, M. J., & Schaberg, D. R. (1985) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.28.3.446 · Cited by 68
Brenzinger, S., Airoldi, M., Ogunleye, A. J., Jugovic, K., Amstalden, M. K., & Brochado, A. R. (2024) · Nature Microbiology · doi:10.1038/s41564-023-01556-y · Cited by 31
Metadata
- Authors
- Bushby, S. R. M.
- Venue
- Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1973-11-01
- Volume
- 128
- Issue
- Supplement 3
- Pages
- S442-S462
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2151619842
- Cited by
- 207
- References
- 1
- FWCI
- 9.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Trimethoprim-Sulfamethoxazole: In Vitro Microbiological Aspects. https://app.cochat.ai/papers/10.1093/infdis/128.supplement_3.s442
- The paper
- Bushby, S. R. M. (1973). Trimethoprim-Sulfamethoxazole: In Vitro Microbiological Aspects. Journal of Infectious Diseases. https://doi.org/10.1093/infdis/128.supplement_3.s442
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.